(Q33665585)

28 July 2017

title

Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder (English)

1 reference

28 July 2017

1

Linda Cardozo

1 reference

28 July 2017

Vik Khullar

2

1 reference

28 July 2017

Ahmed El-Tahtawy

3

1 reference

28 July 2017

Zhonghong Guan

4

1 reference

28 July 2017

Bimal Malhotra

5

1 reference

28 July 2017

David Staskin

6

1 reference

28 July 2017

publication date

19 August 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

14

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

copyright license

start time

19 August 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Urinary retention and post-void residual urine in men: separating truth from tradition

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939595

How modeling and simulation have enhanced decision making in new drug development

28 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939595

Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-10-14

Fesoterodine dose response in subjects with overactive bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-10-14

Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-10-14

Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-10-14

Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-10-14

Pharmacokinetic profile of fesoterodine

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939595

Do oral antimuscarinic drugs carry an increased risk of acute urinary retention?

30 October 2018

1 reference

12 December 2020

Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder

1 reference

12 December 2020

Evaluation of voiding dysfunction and measurement of bladder volume

1 reference

12 December 2020

Pharmacokinetic models for the saturable distribution of paclitaxel

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2490-10-14

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2490-10-14

9 September 2019

1 reference

28 July 2017

1 reference